UK markets closed

Jupiter Emerging European Opportunities J Acc (0P0001JU9I.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
255.60+0.60 (+0.24%)
At close: 08:00PM GMT
Full screen
Previous close255.00
YTD return16.81%
Expense ratio (net)0.00%
CategoryEmerging Europe Equity
Last cap gain0.00
Morningstar rating★★★★★
Morningstar risk ratingAverage
Sustainability rating
Net assets82.88M
Beta (5Y monthly)0.99
Yield2.93%
5y average returnN/A
Holdings turnover166.28%
Last dividend0.00
Average for categoryN/A
Inception date29 May 2020
  • Globe Newswire

    Bone Therapeutics Successfully Raises EUR 3.3 Million in Private Placement

    REGULATED INFORMATION NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO Gosselies, Belgium, 3 December 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the cell therapy company addressing unmet medical needs in orthopedics and other diseases, today announces that it raised EUR 3.3 million in gross pro

  • Globe Newswire

    Bone Therapeutics and Link Health sign a non-binding term sheet for the global rights of ALLOB

    REGULATED INFORMATION Link Health to be granted global rights for development, manufacturing and commercialization of ALLOB Bone Therapeutics to receive R&D cost reimbursement, commercial milestone payments of up to €60 million in total and tiered royalties on net sales of up to 25% upon completion of final agreement The two parties will immediately commence the drafting of a binding License Agreement Gosselies, Belgium, 29 November 2021, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: